← Back to Search

Behavioral Intervention

Resilience Coaching for Adolescent Chronic Pain

N/A
Recruiting
Led By Sabrina Gmuca, MD MSCE
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 3 months post-randomization.
Awards & highlights

Study Summary

This trial will research how resilience coaching could help teens with chronic pain. It'll compare those who receive resilience coaching to those who receive usual care. Results will show if it helps with functional disability, psychological distress, and pain intensity.

Who is the study for?
Adolescents aged 12-17 with chronic musculoskeletal pain, which includes bone, joint, muscle or related soft tissue pain lasting more than 3 months. They must have a caregiver to participate alongside them and both should primarily speak English. Those already receiving cognitive behavioral therapy or diagnosed with complex regional pain syndrome are excluded.Check my eligibility
What is being tested?
The trial is testing the effectiveness of resilience coaching (PRISM) for teens with chronic musculoskeletal pain compared to usual care. It aims to see if PRISM can better improve how these adolescents cope with disability, psychological distress, and pain intensity.See study design
What are the potential side effects?
Since this intervention involves coaching rather than medication, traditional side effects like those seen in drug trials may not apply. However, participants might experience emotional discomfort when discussing personal issues during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 3 months post-randomization.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 3 months post-randomization. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional Disability
Secondary outcome measures
Pain intensity
Psychological distress

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Resilience Coaching plus Usual CareExperimental Treatment1 Intervention
Promoting Resilience in Stress Management (PRISM) is a 1:1, remotely delivered, resilience coaching program for adolescents with chronic illness, consisting of skill-building sessions in stress management, goal setting, cognitive re-framing, and benefit-finding. Sessions are held every 1-2 weeks for a total of 4 required and one optional session and each session lasts about 30-45 minutes.
Group II: Usual CareActive Control1 Intervention
Usual care consists of an individualized treatment combining physical therapy, occupational therapy and psychological counseling. This is determined by the treating provider.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Promoting Resilience in Stress Management
2016
N/A
~110

Find a Location

Who is running the clinical trial?

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
484 Previous Clinical Trials
1,086,767 Total Patients Enrolled
10 Trials studying Chronic Pain
690 Patients Enrolled for Chronic Pain
Children's Hospital of PhiladelphiaLead Sponsor
708 Previous Clinical Trials
8,580,819 Total Patients Enrolled
2 Trials studying Chronic Pain
521 Patients Enrolled for Chronic Pain
Sabrina Gmuca, MD MSCEPrincipal InvestigatorChildren's Hospital of Philadelphia

Media Library

Promoting Resilience in Stress Management (PRISM) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05834725 — N/A
Chronic Pain Research Study Groups: Usual Care, Resilience Coaching plus Usual Care
Chronic Pain Clinical Trial 2023: Promoting Resilience in Stress Management (PRISM) Highlights & Side Effects. Trial Name: NCT05834725 — N/A
Promoting Resilience in Stress Management (PRISM) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05834725 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for participation in this experiment?

"Affirmative. According to clinicaltrials.gov, this ongoing medical trial is soliciting patients from one location in pursuit of 240 participants. The initial post was made on May 8th, 2023 with the latest update having been posted on May 19th, 2023."

Answered by AI

How many participants are eligible to enroll in the clinical trial?

"Indeed, clinicaltrials.gov verifies that this medical trial is still recruiting individuals. It was first posted on May 8th and last updated on the 19th of the same month. 240 patients are required at a single site for completion of the study."

Answered by AI

Who else is applying?

What site did they apply to?
Children's Hospital of Philadelphia
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I experience chronic pain sometimes daily.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

Do I qualify for the study?
PatientReceived 1 prior treatment
~125 spots leftby May 2025